Excellent Outcomes of Hematopoietic Stem Cell Transplant for Pediatric High Risk and Relapsed Acute Myeloid Leukemia–A Decade Long Experience From Developing Nation
HSCT for children with AML from the developing world shows promising outcomes with high survival rates even in the absence of matched donors. Having expertise in multiple specialties, such as a molecular hematologist, infectious disease (ID), and intensive care specialist, can significantly enhance the outcomes for transplant patients.
Authors
- Swati Bhayana (ORCID: https://orcid.org/0000-0003-3783-8846)
- Sunisha Arora (ORCID: https://orcid.org/0000-0003-4531-6546)
- Neha Panda
- Sohini Chakraborty (ORCID: https://orcid.org/0000-0002-6339-7792)
- Anusha Swaminathan
- Rahul Bhargava (ORCID: https://orcid.org/0000-0002-0781-7748)
- Nikhil Kumar
- Arun Danewa
- Madhur Arora
- Parminder Singh (ORCID: https://orcid.org/0000-0002-2851-6805)
- Shrinidhi Nathany (ORCID: https://orcid.org/0000-0001-6006-6309)
- S.C. Pokhriyal
- Vikas Dua
Institutions
- Pediatric Oncology Group (CA)
- Fortis Memorial Research Institute (IN)
- Palmetto Hematology Oncology (US)
Publication Details
- Journal
- Journal of Pediatric Hematology/Oncology
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1097/mph.0000000000003151
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00